Plain-English translation of NCT04941274 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1/2 — A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
This trial is testing a medication called to see if it can treat Kaposi sarcoma, a type of cancer that causes tumors in the skin and sometimes in other parts of the body. is already approved and used to treat breast cancer, and researchers believe it may also help people with Kaposi sarcoma. The study will test whether the medication is safe and effective for this new use.
Kaposi sarcoma is a serious condition that often comes back and requires repeated rounds of strong chemotherapy, which can be hard on the body. Doctors need better treatment options, especially for people whose cancer stops responding to current treatments.
You likely qualify if…
You likely don't qualify if…
You would take the medication by mouth daily. Depending on which group you join, you may be helping doctors find the right dose (Phase I), or testing a dose already determined to be safe (Phase II). Some participants are those who have already tried other treatments; others are being treated for the first time. You will have regular visits to your doctor for blood tests, imaging scans to measure your lesions, and heart checks to make sure the medication is working safely.
AI-generated summary from trial data · Jun 12, 2026 · Not medical advice
United States